Brind.

Financial institutions, including Mizuho and UBS, inquired about Tandem Diabetes Care's commercial launch, path to 60% gross margin, and uptake of pump demand.

1 report, 0 independent Updated Jun 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Mizuho Financial Group UBS Tandem Diabetes Care, Inc.

Keep exploring

The entities involved

Mizuho Financial Group
Japanese holding company
- TFI International announced corporate updates including adding LTL carrier TForce Freight and appointing Steve Mayer to the board. Separately, Mizuho Financial Group completed the acquisition of Greenhill & Co. in 2023.Wed 16:36
UBS
Swiss multinational investment bank and financial services company
- The Trump administration threatens tariffs on Switzerland, leading Switzerland to seek a new trade agreement with the US.Mon 00:13
- Following the acquisition of Credit Suisse, the Swiss parliament proposed new banking regulations for UBS.Sun 10:25
Tandem Diabetes Care, Inc.
U.S. healthcare company
- Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
- Solventum and Tandem Diabetes Care, Inc., two companies in the healthcare sector, are currently facing market comparison.Sun 18:43

Related events

Tandem Diabetes Care is awaiting FDA clearance for its tubeless Tandem Mobi system while also expanding pump adoption through new product launches.Aug 18

Coverage

Newest first; wire copies grouped

Jun 25Unknown outlet